|
US20070117863A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
KR100789008B1
(ko)
*
|
1997-06-27 |
2007-12-26 |
아브락시스 바이오사이언스 인크. |
신규 약물 제제
|
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
|
US8735394B2
(en)
*
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
MX383644B
(es)
*
|
2005-02-18 |
2025-03-14 |
Abraxis Bioscience Llc |
Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion.
|
|
JP5368093B2
(ja)
*
|
2005-08-31 |
2013-12-18 |
アブラクシス バイオサイエンス， エルエルシー |
増大した安定性を有する難水溶性薬剤の組成物および調製の方法
|
|
BRPI0615265A8
(pt)
*
|
2005-08-31 |
2018-03-06 |
Abraxis Bioscience Llc |
composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
|
|
CA2653756A1
(en)
*
|
2006-06-26 |
2008-01-03 |
The University Of British Columbia |
Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers
|
|
US20080280987A1
(en)
*
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
CA2679859A1
(en)
*
|
2006-11-01 |
2008-05-15 |
George Mason Intellectual Properties, Inc. |
Method for detecting and controlling cancer
|
|
EP2117520B1
(en)
|
2006-12-14 |
2018-08-29 |
Abraxis BioScience, LLC |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
EP2131821B1
(en)
*
|
2007-03-07 |
2018-05-09 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
CA2686736A1
(en)
*
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Nanoparticle compositions comprising rapamycin for treating pulmonary hypertension
|
|
DK2155188T3
(da)
*
|
2007-06-01 |
2013-11-04 |
Abraxis Bioscience Llc |
Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
|
|
EP2170319A4
(en)
*
|
2007-06-22 |
2011-10-12 |
Scidose Llc |
SOLVENT FORMULATION FROM DOCETAXEL WITHOUT TWEEN 80
|
|
ITMI20080284A1
(it)
*
|
2008-02-22 |
2009-08-23 |
Indena Spa |
Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
|
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
EP2310006A4
(en)
|
2008-07-03 |
2012-04-25 |
Mayo Foundation |
CANCER TREATMENT
|
|
EP2153821A1
(en)
*
|
2008-08-06 |
2010-02-17 |
BioAlliance Pharma |
Oral formulations of camptothecin derivatives
|
|
ES2528032T3
(es)
*
|
2009-01-16 |
2015-02-03 |
Rigel Pharmaceuticals, Inc. |
Inhibidores de Axl para su uso en terapia de combinación para prevenir, tratar o manejar cáncer metastásico
|
|
JP5725563B2
(ja)
*
|
2009-03-13 |
2015-05-27 |
アブラクシス バイオサイエンス， エルエルシー |
チオコルヒチン誘導体との組み合わせ療法
|
|
EP3626233A1
(en)
|
2009-04-15 |
2020-03-25 |
Abraxis BioScience, LLC |
Prion-free nanoparticle compositions and methods
|
|
JP2012532879A
(ja)
*
|
2009-07-07 |
2012-12-20 |
ノームオキシーズ，インコーポレイテッド |
イノシトールトリピロリン酸を使用して多剤耐性を低減する方法
|
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
|
RU2012140447A
(ru)
*
|
2010-02-23 |
2014-03-27 |
Дженентек, Инк. |
Антиангиогенная терапия для лечения рака яичника
|
|
ES2580135T3
(es)
|
2010-03-26 |
2016-08-19 |
Abraxis Bioscience, Llc |
Métodos de tratamiento de carcinoma hepatocelular
|
|
KR20180050426A
(ko)
*
|
2010-03-29 |
2018-05-14 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
|
KR101894689B1
(ko)
|
2010-03-29 |
2018-09-04 |
아브락시스 바이오사이언스, 엘엘씨 |
암의 치료 방법
|
|
CA2801645A1
(en)
|
2010-06-04 |
2011-12-08 |
Abraxis Bioscience, Llc |
Use of nanoparticules comprising a taxane and an albumin in the treatment of pancreatic cancer
|
|
RU2016103126A
(ru)
*
|
2010-06-07 |
2018-11-22 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы комбинированной терапии для лечения пролиферативных заболеваний
|
|
US20120121510A1
(en)
*
|
2010-11-11 |
2012-05-17 |
Brem Rachel F |
Localized therapy following breast cancer surgery
|
|
WO2012068098A1
(en)
*
|
2010-11-15 |
2012-05-24 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating cancer with dll4 antagonists
|
|
HRP20200793T1
(hr)
|
2011-05-09 |
2020-10-16 |
Mayo Foundation For Medical Education And Research |
Liječenje raka
|
|
TWI558401B
(zh)
|
2011-11-01 |
2016-11-21 |
西建公司 |
利用胞嘧啶核苷類似物之口服配方治療癌症的方法
|
|
WO2013085902A1
(en)
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
|
KR20140107417A
(ko)
|
2011-12-14 |
2014-09-04 |
아브락시스 바이오사이언스, 엘엘씨 |
입자의 동결건조 또는 동결을 위한 중합체 부형제의 용도
|
|
CA2860941C
(en)
*
|
2012-03-13 |
2019-11-05 |
F. Hoffmann-La Roche Ag |
Combination therapy for the treatment of ovarian cancer
|
|
AU2013327638B2
(en)
|
2012-10-01 |
2018-06-14 |
Mayo Foundation For Medical Education And Research |
Cancer treatments
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
HK1218506A1
(zh)
*
|
2013-02-11 |
2017-02-24 |
阿布拉科斯生物科学有限公司 |
治療黑素瘤的方法
|
|
WO2014159171A1
(en)
|
2013-03-12 |
2014-10-02 |
Abraxis Bioscience, Llc |
Methods of treating lung cancer
|
|
SG11201507234UA
(en)
|
2013-03-14 |
2015-10-29 |
Abraxis Bioscience Llc |
Methods of treating bladder cancer
|
|
US10842969B2
(en)
|
2013-10-25 |
2020-11-24 |
Mercator Medsystems, Inc. |
Systems and methods of treating malacia by local delivery of hydrogel to augment tissue
|
|
WO2015134543A1
(en)
*
|
2014-03-05 |
2015-09-11 |
Sorrento Therapeutics, Inc. |
Pharmacokinetically equivalent nanoparticle compositions
|
|
EP2924022A1
(en)
*
|
2014-03-27 |
2015-09-30 |
INDENA S.p.A. |
Amorphous form of a thiocolchicine derivative
|
|
US20160250351A1
(en)
|
2014-06-13 |
2016-09-01 |
Mayo Foundation For Medical Education And Research |
Treating Lymphomas
|
|
JP6600651B2
(ja)
|
2014-06-16 |
2019-10-30 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
骨髄腫の治療
|
|
US20150359810A1
(en)
|
2014-06-17 |
2015-12-17 |
Celgene Corporation |
Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine
|
|
CN104434808A
(zh)
*
|
2014-07-03 |
2015-03-25 |
石药集团中奇制药技术（石家庄）有限公司 |
一种治疗性纳米粒子及其制备方法
|
|
US9446148B2
(en)
|
2014-10-06 |
2016-09-20 |
Mayo Foundation For Medical Education And Research |
Carrier-antibody compositions and methods of making and using the same
|
|
BR112016030965A2
(pt)
*
|
2014-10-06 |
2017-08-22 |
Mayo Found Medical Education & Res |
Composições de veículo-anticorpo e métodos de fabricação e uso das mesmas
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
HUE070408T2
(hu)
|
2015-06-29 |
2025-06-28 |
Abraxis Bioscience Llc |
Szirolimuszt és albumint tartalmazó nanorészecskék epitelioid sejtes tumorok kezelésében történõ alkalmazásra
|
|
JP6921802B2
(ja)
*
|
2015-08-18 |
2021-08-18 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチＭａｙｏ Ｆｏｕｎｄａｔｉｏｎ Ｆｏｒ Ｍｅｄｉｃａｌ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ |
キャリア結合剤組成物およびそれを作製および使用する方法
|
|
TW201707725A
(zh)
|
2015-08-18 |
2017-03-01 |
美國馬友醫藥教育研究基金會 |
載體－抗體組合物及其製造及使用方法
|
|
WO2017176265A1
(en)
*
|
2016-04-06 |
2017-10-12 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
TW201713360A
(en)
|
2015-10-06 |
2017-04-16 |
Mayo Foundation |
Methods of treating cancer using compositions of antibodies and carrier proteins
|
|
CN105288639A
(zh)
*
|
2015-11-23 |
2016-02-03 |
中国药科大学 |
一种载阿霉素的主动靶向白蛋白纳米载体的制备及其应用
|
|
EP3399861A4
(en)
|
2016-01-07 |
2019-08-07 |
Mayo Foundation for Medical Education and Research |
METHOD FOR THE TREATMENT OF CANCER WITH INTERFERON
|
|
WO2017139698A1
(en)
*
|
2016-02-12 |
2017-08-17 |
Mayo Foundation For Medical Education And Research |
Hematologic cancer treatments
|
|
WO2017165440A1
(en)
*
|
2016-03-21 |
2017-09-28 |
Mayo Foundation For Medical Education And Research |
Methods for reducing toxicity of a chemotherapeutic drug
|
|
CA3018340A1
(en)
*
|
2016-03-21 |
2017-09-28 |
Mayo Foundation For Medical Education And Research |
Methods for improving the therapeutic index for a chemotherapeutic drug
|
|
US10618969B2
(en)
|
2016-04-06 |
2020-04-14 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
KR102482503B1
(ko)
*
|
2016-08-05 |
2022-12-30 |
메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 |
암 치료를 위한 변형된 항체-알부민 나노입자 복합체
|
|
US11406684B2
(en)
*
|
2016-08-26 |
2022-08-09 |
Tetsuji Okuno |
Fine nano-sized medicinal agent and use thereof
|
|
CN109890419A
(zh)
|
2016-09-01 |
2019-06-14 |
梅约医学教育与研究基金会 |
用于治疗癌症的载体-pd-l1结合剂组合物
|
|
RU2019109209A
(ru)
|
2016-09-01 |
2020-10-05 |
Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч |
Способ и композиции для направленного на мишень воздействия при лечении т-клеточных видов рака
|
|
WO2018048815A1
(en)
|
2016-09-06 |
2018-03-15 |
Nantibodyfc, Llc |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
KR20230010817A
(ko)
|
2016-09-06 |
2023-01-19 |
메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 |
파클리탁셀-알부민-결합제 조성물 및 그의 사용 및 제조 방법
|
|
JP2019526587A
(ja)
|
2016-09-06 |
2019-09-19 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチＭａｙｏ Ｆｏｕｎｄａｔｉｏｎ Ｆｏｒ Ｍｅｄｉｃａｌ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ |
Ｐｄ−ｌ１を発現する癌を処置する方法
|
|
CN106310291A
(zh)
*
|
2016-09-14 |
2017-01-11 |
东南大学 |
主动靶向抗肿瘤纳米药物及其制备方法和应用
|
|
LT3532059T
(lt)
|
2016-10-27 |
2022-05-25 |
Celgene Quanticel Research, Inc. |
Bromodomeno ir papildomo galinio baltymo inhibitorių derinio terapija
|
|
WO2018081652A2
(en)
*
|
2016-10-28 |
2018-05-03 |
Nant Holdings Ip, Llc |
Avatar dendritic cells: the neoantigen natural killer t-cell chemo immuno radiation composition inducing immunogenic cell death
|
|
BR112020009055A2
(pt)
|
2017-11-06 |
2020-11-03 |
Rapt Therapeutics, Inc. |
moduladores de receptor de quimiocina para tratamento de câncer positivo para vírus epstein barr
|
|
WO2019104042A1
(en)
*
|
2017-11-21 |
2019-05-31 |
University Of Iowa Research Foundation |
Synthetically lethal nanoparticles for treatment of cancers
|
|
AU2018388579A1
(en)
*
|
2017-12-19 |
2020-07-09 |
Abraxis Bioscience, Llc |
Methods of treating colon cancer using nanoparticle mTOR inhibitor combination therapy
|
|
WO2019147944A1
(en)
|
2018-01-26 |
2019-08-01 |
The Regents Of The University Of California |
Methods and compositions for treatment of angiogenic disordres using anti-vegf agents
|
|
AU2019239953B2
(en)
|
2018-03-20 |
2025-01-02 |
Abraxis Bioscience, Llc |
Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin
|
|
KR20220106758A
(ko)
|
2019-10-28 |
2022-07-29 |
아브락시스 바이오사이언스, 엘엘씨 |
알부민 및 라파마이신의 제약 조성물
|
|
CA3168512A1
(en)
|
2019-11-25 |
2021-06-03 |
Napoleone Ferrara |
Long-acting vegf inhibitors for intraocular neovascularization
|
|
KR102263606B1
(ko)
|
2020-02-11 |
2021-06-10 |
충북대학교 산학협력단 |
파클리탁셀과 알피늄이소플라본을 함유한 나노 마이셀, 이의 제조방법 및 이의 용도
|